A single large milkshake’s worth of sugar around an antibiotic course tracked with a steeper gut wipeout.
Story Highlights
- Higher sugar intake during antibiotics linked to larger drops in gut diversity
- Signals point to Enterococcus faecium expansion when sugar and antibiotics mix
- Mouse tests mirrored the human pattern, adding biological support
- Doctors logged thousands of meals and hundreds of stool samples in hospital patients
What the researchers actually found
Researchers tracking diet and stool samples in hospitalized patients saw a clear pattern. People who ate more high-sugar foods while on antibiotics lost more types of gut bacteria than those who ate less sugar. Coverage pegs the drop at about a 24 percent greater hit in diversity for each extra 100 grams of sugary foods or drinks, roughly a big milkshake’s worth. The preprint quantifies the link as an added median decrease in alpha-diversity for each 100-gram bump in sweets intake.
The same reports spotlight a second signal that matters in real-life care. When sugar intake rose during or after an antibiotic course, Enterococcus faecium tended to bloom. This microbe thrives when antibiotics thin the competition. Hospitals know it well. It can cause tough infections and often resists many drugs. That makes any diet-antibiotic mix that feeds Enterococcus faecium a practical concern, not a lab oddity.
Why Enterococcus faecium raises red flags
Enterococcus species are classic survivors. They tolerate many common antibiotics and can collect new resistance over time. Clinical reviews describe broad built-in resistance in these bacteria, including to cephalosporins and other routine drugs. If a patient’s microbiome loses balance, these hardy bugs can step in and take over space and resources. That shift can turn a routine recovery into a risk for infection and longer hospital care, which is why this signal draws attention.
Press summaries and the preprint agree on the direction of the effect. Sugar during antibiotic exposure linked to lower diversity and more Enterococcus. The authors phrase it as observational evidence, not a randomized test, which matters for method but does not erase the core pattern. The practical read is simple: when antibiotics clear the field, easy sugars can feed the wrong winners. Cutting sugar in that window may help protect the good neighbors left behind.
How they built the case
The team did not stop at human meal logs and stool reads. They moved to controlled mouse models. When mice got both sucrose and an antibiotic, Enterococcus rose more than with antibiotic alone, matching the human link and adding biological support. A conference abstract in Blood reported the same direction in patients after allogeneic stem cell transplant, with strong fold-changes in Enterococcus at days three and six after exposure, and showed that glucose and fructose alone could push the bloom.
Slashing sugar intake before antibiotics may save your microbiome https://t.co/Bmw3lqTAws pic.twitter.com/jXRgtdY5Hn
— New Scientist (@newscientist) September 30, 2026
Hospital records anchored the real-world side. Reports cite 9,419 meals logged for 173 inpatients and microbiome profiles from 158 patients, giving a dense map of diet alongside gut changes. The detail supports the core idea that food choices, even at the dessert tray, can tilt recovery in a gut under antibiotic pressure. While this was not a general outpatient sample, the pattern tracks with known ecology: remove competitors, add simple fuel, watch opportunists rise.
What to do the next time antibiotics are needed
Common sense lines up with the data: follow the doctor’s orders on the drug, but do not feed the fire. Skip sweets and sugar-sweetened drinks during the course and for a short period after. Favor protein, vegetables, and fiber-rich foods that your helpful bacteria can use. This is not a moral crusade; it is basic biology. Do not give tough microbes an easy meal while their rivals are down. That is the conservative choice that respects risk and rewards prudence.
Limits and next steps without the fine print fatigue
The human data are observational in a hospital setting, so other factors could play a role. That caveat aside, the alignment between meal logs, stool profiles, and animal tests makes the pattern hard to shrug off. Next steps are clear: confirm in outpatients, compare antibiotic classes, and track clinical outcomes like infection and length of stay. Until then, the lowest-cost hedge is simple: when antibiotics are on board, hold the sweets.
Sources:
newscientist.com, kxan.com, businesswire.com, tandfonline.com, journals.asm.org, link.springer.com
